Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page; no changes to study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-01-13T16:52:51.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Removed the term 'Multiple myeloma' from the page content and deleted the MedlinePlus Genetics related topic.
    Difference
    0.1%
    Check dated 2026-01-06T16:27:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics; the page revision updated to v3.3.3. Removed the HHS Vulnerability Disclosure link and updated the footer revision from v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T08:52:34.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Removed related topics links for 'Multiple Myeloma' and 'MedlinePlus Genetics' from the page. This affects navigation references but does not modify core trial content.
    Difference
    0.1%
    Check dated 2025-12-16T02:41:42.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 in the page footer. No other visible changes to the study details or page layout.
    Difference
    0.0%
    Check dated 2025-12-01T17:39:50.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' and related topics (MedlinePlus Genetics). Included a note that publications are automatically filled from PubMed and updated the revision tag to v3.3.1.
    Difference
    0.2%
    Check dated 2025-11-24T14:47:23.000Z thumbnail image

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.